Interrelationship of cardiovascular effects, plasma levels of nicorandil, and vascular cGMP formation in conscious rats

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 6, 1998, Pages 661-666

  Sakai, Kazushige ^a   Akima, Michitaka ^a   Kamachi, Shinichi ^a   Moriyasu, Matsuko ^b   Kitajima, Shunichi ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b Panapharm Laboratories Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; GLIBENCLAMIDE; NICORANDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMORAL ARTERY FLOW; HEART RATE; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; THORACIC AORTA; VASCULAR RESISTANCE; VASODILATATION;

EID: 0031804942     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb06902.x     Document Type: Article

References (18)

1. Cavero, I., Mondot, S., Mestre, M. (1989) Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J. Pharmacol. Exp. Ther. 248: 1261-1268
2. Clapham, J. C., Hamilton, T. C., Longman, S. D., Buckingham, R. E., Campbell, C. A. (1991) Antihypertensive and haemodynamic properties of the potassium-channel activating (-) enantiomer of cromakalim in animal models. Arzneim. Forsch. 41: 385-391
3. 2 receptor-mediated vasodepression does not involve a pertussis toxin-sensitive G protein. Eur. J. Pharmacol. 236: 255-262
4. Hamilton, T. C., Weston, A. H. (1989) Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen. Pharmacol. 20: 1-9
5. Haywood, J. R., Shaffer, R. A., Fastenow, L., Fink, G. D., Brody, M. J. (1981) Regional blood flow measurements in the conscious rat with a pulsed Doppler flowmeter. Am. J. Physiol. 241: 4273-4278
6. Kinoshita, M., Sakai, K. (1990) Pharmacology and therapeutic effects of nicorandil. Cardiovasc. Drugs Ther. 4: 1075-1088
7. Kreye, V. A. W., Lenz, T., Pfrunder, D. (1993) Mode of action of potassium-channel openers in vascular smooth muscle. Rev. Contemp. Pharmacother. 4: 185-198
8. Krumenacker, M., Roland, E. (1992) Clinical profile of nicorandil: an overview of its haemodynamic properties and therapeutic efficacy. J. Cardiovasc. Pharmacol. 20: S93-S102
9. Kukovetz, W. R., Holzmann, S. (1987) Cyclic GMP in nicorandil-induced vasodilatation and tolerance development. J. Cardiovasc. Pharmacol. 10: S25-S30
10. Saito, K., Sakai, K. (1998) Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim. Fundam. Clin. Pharmacol. 12: 37-43
11. Sakai, K. (1989) Nicorandil: animal pharmacology. Am. J. Cardiol. 63: 2J-10J
12. Sakai, K., Ohba, Y., Akima, M., Kamiyama, H., Hinohara, Y., Nakano, H. (1980) Pharmacodynamic and metabolism studies on a new coronary vasodilator, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75). Jpn J. Pharmacol. 30: 881-890
13. Sakai, K., Akima, M., Hinohara, Y., Obatake, N. (1984) Hypotensive effects and biotransformation of nicorandil, a new antianginal agent, administered to rats by different routes: comparison with nitroglycerine and isosorbide dinitrate. J. Pharm. Pharmacol. 36: 175-181
14. Sakai, K., Moriyasu, M., Kitajima, S., Akima, M., Kamachi, S., Tanikawa, M. (1998) Vascular levels and cGMP increasing effects of nicorandil administered orally to rats. J. Cardiovasc. Pharmacol. 31: 595-600
15. Shiraki, Y., Akima, M., Nabata, H., Ohba, Y., Hoshino, E., Sakai, K. (1981) The hypotensive mechanisms of the new anti-anginal drug, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) in beagle dogs. Jpn J. Pharmacol. 31: 921-929
16. Taira, N. (1989) Nicorandil as a hybrid between nitrates and potassium channel activators. Am. J. Cardiol. 63: 18J-24J
17. Taira, N., Satoh, K., Yanagisawa, T., Imai, Y., Hiwatari, M. (1979) Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidethyl nitrate (SG-75). Clin. Exp. Pharmacol. Physiol. 6: 301-316
18. Yanagisawa, T., Taira, N. (1980) Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance. Naunyn Schmiedebergs Arch. Pharmacol. 312: 69-76